Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian CellsRobert I. Lehrer, Tomas Ganz, Alan Lichtenstein|Annual Review of Immunology|1993Cited by 991
AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc ExpressionJoseph Gera, Alan Lichtenstein|Journal of Biological Chemistry|2004Cited by 329
RETRACTED: Downstream effectors of oncogenic ras in multiple myeloma cellsLiping Hu, Alan Lichtenstein|Blood|2003Cited by 143
Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitorBao Hoang, Alan Lichtenstein|Blood|2010Cited by 120
Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal–regulated kinase inhibitors and rapamycinPatrick Frost, Alan Lichtenstein|Molecular Cancer Therapeutics|2009Cited by 30